COMPANY

Akorn, Inc.

Name: Akorn, Inc. peptide roles
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

Akorn, Inc.: recalling firm for Bacitracin, Cetrorelix, as stated by public registers.

RECALLING FIRM

Recalled a product naming the peptide (FDA enforcement report).

Bacitracin	Class II recall, Ongoing, 2023-01-25 Regulator openFDA
Bacitracin	Class II recall, Ongoing, 2023-06-07 Regulator openFDA
Cetrorelix	Class II recall, Ongoing, 2023-06-07 Regulator openFDA

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.